Current Ratio in % of AGILE THERAPEUTICS INC from Q1 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Agile Therapeutics Inc quarterly Current Ratio history and change rate from Q1 2015 to Q2 2024.
  • Agile Therapeutics Inc Current Ratio for the quarter ending 30 Jun 2024 was 53.5 %, a 36.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2024 53.5 -30.4 -36.2% 30 Jun 2024
Q1 2024 57.6 -20.1 -25.9% 31 Mar 2024
Q4 2023 58.4 -16.5 -22% 31 Dec 2023
Q3 2023 67.9 -7.66 -10.1% 30 Sep 2023
Q2 2023 83.9 -0.05 -0.06% 30 Jun 2023
Q1 2023 77.7 -49.3 -38.8% 31 Mar 2023
Q4 2022 74.9 -138 -64.9% 31 Dec 2022
Q3 2022 75.6 -351 -82.3% 30 Sep 2022
Q2 2022 84 -518 -86.1% 30 Jun 2022
Q1 2022 127 -753 -85.6% 31 Mar 2022
Q4 2021 213 -1.1K -83.8% 31 Dec 2021
Q3 2021 426 -1.01K -70.4% 30 Sep 2021
Q2 2021 602 -988 -62.1% 30 Jun 2021
Q1 2021 880 -681 -43.6% 31 Mar 2021
Q4 2020 1.31K +431 +48.9% 31 Dec 2020
Q3 2020 1.44K +735 +104% 30 Sep 2020
Q2 2020 1.59K +1.23K +348% 30 Jun 2020
Q1 2020 1.56K +1.29K +474% 31 Mar 2020
Q4 2019 883 +649 +278% 31 Dec 2019
Q3 2019 704 +470 +201% 30 Sep 2019
Q2 2019 355 +76.8 +27.6% 30 Jun 2019
Q1 2019 272 -31.9 -10.5% 31 Mar 2019
Q4 2018 234 -107 -31.5% 31 Dec 2018
Q3 2018 234 -167 -41.6% 30 Sep 2018
Q2 2018 278 -171 -38.1% 30 Jun 2018
Q1 2018 304 -212 -41.1% 31 Mar 2018
Q4 2017 341 -283 -45.3% 31 Dec 2017
Q3 2017 401 -242 -37.6% 30 Sep 2017
Q2 2017 450 -178 -28.3% 30 Jun 2017
Q1 2017 516 -169 -24.7% 31 Mar 2017
Q4 2016 624 -104 -14.3% 31 Dec 2016
Q3 2016 642 -62.8 -8.91% 30 Sep 2016
Q2 2016 627 -94.3 -13.1% 30 Jun 2016
Q1 2016 686 -60.4 -8.1% 31 Mar 2016
Q4 2015 728 31 Dec 2015
Q3 2015 705 30 Sep 2015
Q2 2015 722 30 Jun 2015
Q1 2015 746 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.